Suppr超能文献

用通用名药物替代品牌名药物可能节省的费用:1997 - 2000年医疗支出小组调查

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

作者信息

Haas Jennifer S, Phillips Kathryn A, Gerstenberger Eric P, Seger Andrew C

机构信息

Brigham and Women's Hospital, Division of General Medicine and Primary Care, Boston, Massachusetts 02120, USA.

出版信息

Ann Intern Med. 2005 Jun 7;142(11):891-7. doi: 10.7326/0003-4819-142-11-200506070-00006.

Abstract

BACKGROUND

Generic substitution is one mechanism of curtailing prescription drug expenditures. Limited information is available about the potential savings associated with generic substitution.

OBJECTIVE

To estimate the potential savings associated with broad substitution of generic drugs.

DESIGN

Cross-sectional, nationally representative survey of noninstitutionalized adults.

SETTING

United States.

PARTICIPANTS

Adults included in the Medical Expenditure Panel Survey Household Component, 1997-2000.

MEASUREMENTS

Use of a multisource drug (that is, a drug available in a brand-name and > or =1 generic formulation) or a generic drug and the potential cost savings associated with broad generic substitution for all multisource products.

RESULTS

Fifty-six percent of all outpatient drugs were multisource products, accounting for 41% of total outpatient drug expenditures. Of these multisource drugs, 61% were dispensed as a generic. If a generic had been substituted for all corresponding brand-name outpatient drugs in 2000, the median annual savings in drug expenditures per person would have been 45.89 dollars (interquartile range, 10.35 dollars to 158.06) for adults younger than 65 years of age and 78.05 dollars (interquartile range, 19.94 dollars to 241.72 dollars) for adults at least 65 years of age. In these age groups, the national savings would have been 5.9 billion dollars (95% CI, 5.5 billion dollars to 6.2 billion dollars) and 2.9 billion dollars (CI, 2.6 billion dollars to 3.1 billion dollars), respectively, representing approximately 11% of drug expenditures.

LIMITATIONS

Specific information about an individual's formulary was not available, so the authors could not estimate how much of the potential savings would benefit an individual or his or her health plan.

CONCLUSION

Although broad substitution of generic drugs would affect only a modest percentage of drug expenditures, it could result in substantial absolute savings.

摘要

背景

通用名药物替代是削减处方药支出的一种机制。关于通用名药物替代可能带来的节省情况,现有信息有限。

目的

评估通用名药物广泛替代可能带来的节省情况。

设计

对非机构化成年人进行的具有全国代表性的横断面调查。

地点

美国。

参与者

1997 - 2000年医疗支出小组调查家庭部分中的成年人。

测量指标

使用多源药物(即有品牌名和≥1种通用名制剂的药物)或通用名药物,以及所有多源产品广泛通用名替代可能带来的成本节省。

结果

所有门诊药物中有56%是多源产品,占门诊药物总支出的41%。在这些多源药物中,61%是以通用名形式配药的。如果在2000年所有相应的品牌名门诊药物都被通用名药物替代,65岁以下成年人每人每年药物支出的中位数节省将为45.89美元(四分位间距为10.35美元至158.06美元),65岁及以上成年人则为78.05美元(四分位间距为19.94美元至241.72美元)。在这些年龄组中,全国节省分别为59亿美元(95%CI,55亿美元至62亿美元)和29亿美元(CI,26亿美元至31亿美元),约占药物支出的11%。

局限性

无法获得关于个人处方集的具体信息,因此作者无法估计潜在节省中有多少会使个人或其健康计划受益。

结论

尽管通用名药物的广泛替代只会影响一小部分药物支出,但可能会带来可观的绝对节省。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验